Emily Gallegos, MD
Family Medicine · Cheyenne, WYNPI 1972170058
Payments from drug & device makers
Across 26 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$68
- Novo Nordisk$64
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$63
- AstraZeneca$51
- Exact Sciences$32
- Phadia US Inc.$32
- plus $186 from 9 others
What the payments were for
- Food & beverage$497100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 4 | $68 |
| Novo Nordisk | 3 | $64 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $63 |
| AstraZeneca | 3 | $51 |
| Exact Sciences | 2 | $32 |
| Phadia US Inc. | 2 | $32 |
| Novartis | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Dexcom, Inc. | 1 | $24 |
| GSK | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Merck | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
How this compares
$497 in reported general payments places this provider in the 70th percentile of 237 family medicine providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $13,967 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $873 |
| Ventolin HfaAlbuterol Sulfate | 13 | $863 |
| Atorvastatin Calcium | 66 | $772 |
| Tizanidine Hcl | 18 | $470 |
| Omeprazole | 29 | $460 |
| Levothyroxine Sodium | 53 | $427 |
| Pantoprazole Sodium | 38 | $319 |
| Losartan Potassium | 38 | $314 |
| Metoprolol Succinate | 30 | $305 |
| Tramadol Hcl | 19 | $300 |
| Chlorthalidone | 12 | $284 |
| Amlodipine Besylate | 33 | $277 |
| Gabapentin | 27 | $276 |
| Lisinopril | 38 | $269 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Cheyenne
- John BabsonCheyenne$114K
- Jonathon MedinaCheyenne$6K
- Carol FischerCheyenne$6K
- Douglas EdgrenCheyenne$5K
- Nancy BergquistCheyenne$3K
- Amy HarnishCheyenne$2K
- Joseph DobsonCheyenne$2K
- Gregory StampfliCheyenne$2K
- Samuel HartCheyenne$2K
- Aaron FreemanCheyenne$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.